Clinical Trial Update: Vilazodone for the Treatment of Posttraumatic Stress Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on vilazodone for posttraumatic stress disorder; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Posttraumatic Stress Disorder

Drugs mentioned

• Vilazodone (vilazodone)

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: PTSD, Depression | Phase 4 | Status: COMPLETED